W. Gallmeier

发表

C. Schmidt, D. Hossfeld, W. Boecker, 1975, Nature.

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck

F. Cavalli, M. Rozencweig, P. Dodion, 1984, Cancer.

HL-A antigens in Hodgkin's disease and multiple myeloma. Increased frequency of W18 in both diseases.

C. Schmidt, H. Reis, O. Wetter, 2008, Tissue antigens.

New strategies for prophylactic platelet transfusion in patients with hematologic diseases.

G. Ehninger, H. Wandt, W. Gallmeier, 2001, The oncologist.

Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?

M. Nicolson, J. Smyth, R. Coleman, 1991, BMJ.

Comparison of three tropisetron-containing antiemetic regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nausea

M. Bangerter, S. Drechsler, M. Untch, 1997, Supportive Care in Cancer.

Regulation of the density of the stem cell factor receptor (c-kit) by tumor necrosis factor alpha on a human myeloid cell line.

S. Corbacioglu, M. Smetak, J. Birkmann, 1993, European cytokine network.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces the density of stem cell factor receptors (c-kit oncogene product) on a GM-CSF-dependent human myeloid cell line.

K. Welte, M. Smetak, J. Birkmann, 1993, European cytokine network.

Effects of Recombinant Human Thrombopoietin Alone and in Combination with Erythropoietin and Early‐Acting Cytokines on Human Mobilized Purified CD34+ Progenitor Cells Cultured in Serum‐Depleted Medium

M. Smetak, J. Birkmann, W. Gallmeier, 1997, Stem cells.

Hyper-IL-6 (H-IL-6), a Fusion Protein of Soluble IL-6 Receptor (Sil-6R), and Interleukin-6 (IL-6), Acts Synergistic with Thrombopoietin (TPO) and Stem Cell Factor (SCF) in Expanding Megakaryocyte Progenitors from Human Cd34++/Cd90+ Cell

S. Rose-John, M. Smetak, J. Birkmann, 1999 .

Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysine

H. Wandt, U. Bruntsch, W. Gallmeier, 2004, Investigational New Drugs.

Paraproteinemia and Reticulum Cell Sarcoma in an Inbred Mouse Strain

H. Wanebo, L. Old, E. Boyse, 1966, Science.

Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor

M. Seifert, H. Wandt, C. Falge, 1993, Annals of Hematology.

The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications.

H. Wandt, J. Birkmann, K. Schäfer-Eckart, 1999, Journal of hematotherapy & stem cell research.

T and B lymphocytes in Hodgkin's disease

C. Schmidt, U. Bruntsch, W. Gallmeier, 1973, Zeitschrift für Krebsforschung und Klinische Onkologie.

Tumorimmunologie*

W. Gallmeier, Herbert F. Oettgen, Gallmeier Wm, 1968 .

[Ewing sarcoma cells in tissue culture: cytology and verification of virus particles].

C. Hertenstein, K. Lickfeld, W. Gallmeier, 1971, Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology.

Lack of response in nine patients with breast cancer treated with fibroblast interferon

P. Hofschneider, U. Bruntsch, W. Gallmeier, 1984, Cancer Chemotherapy and Pharmacology.

Low‐dose oral natural human interferon-α in 29 patients with HIV‐1 infection: a double‐blind, randomized, placebo‐controlled trial

J. Cummins, H. Jaeger, J. Birkmann, 1992 .

Clinical Status of L-Asparaginase and Side Effects

C. Schmidt, H. Stier, W. Gallmeier, 1970 .

[On blood coagulation disorders during enzyme therapy of malignant tumors and hemoblastoses].

C. Schmidt, H. Stier, W. Gallmeier, 1969, Deutsche medizinische Wochenschrift.

[On the enzyme therapy of leukemias].

C. Schmidt, W. Gallmeier, 1968, Deutsche medizinische Wochenschrift.

Epstein-Barr-Virus- und lymphocytotoxische Serumantikörper in Sarkoidose-Patienten

J. Kalden, C. Hertenstein, W. Gallmeier, 1972, Klinische Wochenschrift.

Characterization of a human Hodgkin cell line and a lymphoblastic EBNA-negative cell line derived from a non-Hodgkin lymphoma patient.

C. Schmidt, U. Bruntsch, D. Hossfeld, 1977, Haematology and blood transfusion.

Diagnosis of Both c-ALL and Sarcoidosis in the Same Patient

H. Wandt, K. Schäfer, W. Gallmeier, 1992 .

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in squamous cell carcinoma of the head and neck

P. Dodion, U. Bruntsch, W. Gallmeier, 1982 .

LW/SO cell line: A tool for studying the phenotypical characterization and commitment of hematopoietic stem cells

E. Gebhart, U. Trautmann, M. Smetak, 1996, Annals of Hematology.

A New Treatment Option in Patients with Cutaneous Lesions from Breast Cancer: Topical Administration of Miltefosine

H. Wandt, W. Gallmeier, 1994 .

Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine / oncology and haematology

M. Horneber, U. Bruntsch, W. Gallmeier, 2000, Supportive Care in Cancer.

[Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].

U. Bruntsch, W. Gallmeier, G. Groos, 2008, Deutsche medizinische Wochenschrift.

Microangiopathic hemolytic anemia, a frequent complication of mitomycin therapy in cancer patients.

U. Bruntsch, W. Gallmeier, G. Groos, 1984, European journal of cancer & clinical oncology.

[cis-Diamino-dichloro-platinum (II) in the treatment of otherwise treatment-resistant malignant testicular teratoma (author's transl)].

S. Seeber, R. Osieka, C. Schmidt, 1976, Deutsche Medizinische Wochenschrift.

cis-Diamino-dichloro-platin (II) in der Behandlung therapieresistenter maligner Hodenteratome

S. Seeber, R. Osieka, U. Bruntsch, 1976 .

[Enzyme therapy--a new principle in the management of malignant tumors and hemoblastoses].

C. Schmidt, W. Gallmeier, 1968, Deutsche medizinische Wochenschrift.

Transient lymphocyte HL-A antigen "loss" in a case of irradiated M. Hodgkin.

C. Schmidt, H. Reis, J. Bertrams, 2008, Tissue antigens.

Mikroangiopathische hämolytische Anämie als Komplikation bei Mitomycin-C-Therapie

U. Bruntsch, W. Gallmeier, G. Groos, 1982 .